drugset / Trial / NCT06775366

The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function

NCT06775366

RandomizedParallel-groupDouble-blindPrevention

Summary

This study want to observe the effects of remimazolam and propofol for general anesthesia on postoperative rhythm and cognitive function. The observation group was given remimazolam for general anesthesia, and the control group was given propofol for general anesthesia. Both drugs are commonly used as intravenous anesthetics for general anesthesia and have been shown to be safe for use in general anesthesia. The investigators hope can understand the effects of remimazolam and propofol for general anesthesia on rhythm status and cognitive function through this study, further reduce the occurrence of postoperative cognitive function impairment, and enable subjects to better recover.

Timeline

Start
2025-02-24
Primary completion
2026-04-30
Completion
2026-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 4 mg/kg Intravenous
Comparator Propofol Small molecule 10 mg/kg Intravenous
Subject Remimazolam Small molecule 1 mg/kg Intravenous
Background Rocuronium Other / unclassified 0.6 mg/kg Intravenous
Background Sevoflurane Other / unclassified
Background Sufentanil Other / unclassified 0.5 ug/kg Intravenous